Goldman Sachs Group Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $2.63 Million - $3.24 Million	-149,105 Reduced 16.4%	760,107 $15 Million
Q4 2023 Feb 13, 2024	BUY	$14.37 - $19.07 $624,089 - $828,210	43,430 Added 5.02%	909,212 $15.9 Million
Q3 2023 May 14, 2024	SELL	$13.62 - $20.2 $591,516 - $877,286	-43,430 Reduced 4.78%	865,782 $15 Million
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $6.73 Million - $9.98 Million	494,264 Added 133.04%	865,782 $15 Million
Q2 2023 May 14, 2024	SELL	$10.44 - $16.48 $526,332 - $830,839	-50,415 Reduced 11.95%	371,518 $5.23 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $526,332 - $830,839	-50,415 Reduced 11.95%	371,518 $5.23 Million
Q1 2023 May 14, 2024	SELL	$10.7 - $15.79 $6.36 Million - $9.38 Million	-593,975 Reduced 58.47%	421,933 $4.54 Million
Q1 2023 May 11, 2023	SELL	$10.7 - $15.79 $6.36 Million - $9.38 Million	-593,975 Reduced 58.47%	421,933 $4.54 Million
Q4 2022 May 14, 2024	BUY	$11.42 - $17.05 $1.26 Million - $1.89 Million	110,640 Added 12.22%	1,015,908 $15.2 Million
Q4 2022 Feb 13, 2023	BUY	$11.42 - $17.05 $1.26 Million - $1.89 Million	110,640 Added 12.22%	1,015,908 $15.2 Million
Q3 2022 May 14, 2024	BUY	$9.76 - $13.41 $2.65 Million - $3.64 Million	271,364 Added 42.81%	905,268 $11.6 Million
Q3 2022 Nov 10, 2022	BUY	$9.76 - $13.41 $2.65 Million - $3.64 Million	271,364 Added 42.81%	905,268 $11.6 Million
Q2 2022 May 14, 2024	SELL	$7.6 - $11.41 $2.09 Million - $3.14 Million	-275,308 Reduced 30.28%	633,904 $6.14 Million
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $2.3 Million - $3.45 Million	-302,700 Reduced 32.32%	633,904 $6.14 Million
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $3.32 Million - $4.42 Million	357,387 Added 61.7%	936,604 $9.31 Million
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $931,401 - $1.36 Million	89,644 Added 18.31%	579,217 $6.82 Million
Q3 2021 Nov 10, 2021	BUY	$11.39 - $16.23 $5.58 Million - $7.95 Million	489,573 New	489,573 $5.58 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account